Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,710 | -2,070 | -6,890 | -4,980 | -3,380 |
| Depreciation Amortization | 10 | 5 | 80 | 60 | 40 |
| Other Working Capital | 190 | 280 | -160 | -110 | -480 |
| Other Operating Activity | 20 | 5 | 710 | 550 | 360 |
| Operating Cash Flow | $-3,490 | $-1,780 | $-6,260 | $-4,480 | $-3,460 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | 0 | -2 | -4 | -5 |
| Other Investing Activity | -5,080 | -1,390 | 4,472 | 5,414 | 2,235 |
| Investing Cash Flow | $-5,100 | $-1,390 | $4,470 | $5,410 | $2,230 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 8,850 | 8,680 | 140 | 150 | 130 |
| Financing Cash Flow | $8,850 | $8,680 | $140 | $150 | $130 |
| Beginning Cash Position | 70 | 70 | 1,710 | 1,710 | 1,710 |
| End Cash Position | 320 | 5,570 | 70 | 2,800 | 610 |
| Net Cash Flow | $250 | $5,500 | $-1,640 | $1,080 | $-1,090 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,490 | -1,780 | -6,260 | -4,480 | -3,460 |
| Free Cash Flow | -3,490 | -1,780 | -6,260 | -4,480 | -3,460 |